Genus Capital Management’s Ambev ABEV Stock Holding History

Genus Capital Management’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$194K	Hold	66,608	–	–	0.02%	212
2026 Q2	$209K	Hold	66,608	–	–	0.02%	197
2026 Q1	$194K	Sell	66,608 -5,000	-7%	-$14.3K	0.02%	185
2025 Q4	$177K	Hold	71,608	–	–	0.02%	191
2025 Q3	$160K	Buy	71,608 +10,000	+16%	+$22.9K	0.02%	199
2025 Q2	$148K	Sell	61,608 -4,392	-7%	-$10.7K	0.02%	178
2025 Q1	$154K	Buy	+66,000	New	+$132K	0.02%	177
2024 Q2	–	Sell	-40,000	Closed	-$91.1K	–	194
2024 Q1	$99.2K	Buy	+40,000	New	+$104K	0.01%	193

Other funds holding ABEV

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

RWC Asset Management London, United Kingdom $2.7B AUM 20.82% 1-Year Est. Return

Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Genus Capital Management's ABEV Position: Q3 2026 in Review

Genus Capital Management held its Ambev (ABEV) position steady in Q3 2026 at 66,608 shares worth $194K. The position accounts for 0.02% of the portfolio, ranked #212.

Genus Capital Management first reported a position in ABEV in Q1 2024 and has held it in 8 quarters since. The position peaked at $209K in Q2 2026. 274 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

Genus Capital Management held 66,608 shares of Ambev worth $194K as of Q3 2026.
Genus Capital Management left its Ambev share count unchanged in Q3 2026.
Ambev made up 0.02% of Genus Capital Management's portfolio in Q3 2026, its #212 holding.
Genus Capital Management first reported a position in Ambev in Q1 2024 and has held it in 8 quarters since.
Genus Capital Management's Ambev position peaked at $209K in Q2 2026.
274 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Genus Capital Management's 13F filing for Q3 2026, filed 4 Nov 2026.